Skip to content

Sisomicin

ANTIINFECTIVES FOR SYSTEMIC USE

Also known as: rickamicin, siseptin, sisomicin sulfate

YEAR INTRODUCED approvedATC J01GB08

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Sisomicin is a drug catalogued in DrugCentral. It was first approved by the YEAR INTRODUCED in 1977. DrugCentral lists 1 molecular target, including rpsL.

  • Molecular targets: rpsL (1 listed in DrugCentral).
  • ATC code: J01GB08 (Other aminoglycosides).
  • Molecular formula: C19H37N5O7; molecular weight 447.53 g/mol.

Mechanism & targets

Molecular targets (1)

TargetGeneActionActivity
30S ribosomal protein S12rpsLunknown—

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1977-01-01YEAR INTRODUCED——

ATC classification

ATC codeTherapeutic hierarchy
J01GB08ANTIINFECTIVES FOR SYSTEMIC USE › ANTIBACTERIALS FOR SYSTEMIC USE › AMINOGLYCOSIDE ANTIBACTERIALS › Other aminoglycosides

Chemical structure

Molecular formulaC19H37N5O7
Molecular weight447.53 g/mol
CAS number32385-11-8
InChIKeyURWAJWIAIPFPJE-YFMIWBNJSA-N
PubChem CID36119
CN[C@@H]1[C@@H](O)[C@@H](O[C@H]2[C@H](N)C[C@H](N)[C@@H](O[C@H]3OC(CN)=CC[C@H]3N)[C@@H]2O)OC[C@]1(C)O

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

How does Sisomicin work?

Its molecular targets in DrugCentral include rpsL.

When was Sisomicin first approved?

Sisomicin was first approved by the YEAR INTRODUCED in 1977.

What is the chemical formula of Sisomicin?

Sisomicin has the molecular formula C19H37N5O7 and a molecular weight of 447.53 g/mol.

Browse: all drugs starting with S · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval1977-01-01
AgencyYEAR INTRODUCED
Targets1
Indications0
FormulaC19H37N5O7
DrugCentral ID2447
Interactive profile